Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. 18:00:00 2024-07-18 EDT 5-day change 1st Jan Change
30.4 CNY +0.26% Intraday chart for Changchun BCHT Biotechnology Co. -2.16% -44.54%
Chart Changchun BCHT Biotechnology Co.
More charts
Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
30.4 CNY
Average target price
54.56 CNY
Spread / Average Target
+79.49%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688276 Stock
  4. News Changchun BCHT Biotechnology Co.
  5. Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine